ARK ETF TR - GENOMIC REV ETF (ARKG)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / GENOMIC REV ETF
Total 13F shares
11,839,290
Share change
+2,641,671
Total reported value
$755,235,763
Put/Call ratio
44%
Price per share
$63.71
Number of holders
235
Value change
+$171,057,097
Number of buys
171
Number of sells
50

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q3 2020

As of 30 Sep 2020 ARK ETF TR - GENOMIC REV ETF (ARKG) had 235 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 11,839,290 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, UBS Group AG, LPL Financial LLC, MAINSTAY CAPITAL MANAGEMENT LLC /ADV, BANK OF AMERICA CORP /DE/, Carroll Financial Associates, Inc., WELLS FARGO & COMPANY/MN, COMMONWEALTH EQUITY SERVICES, LLC, RAYMOND JAMES & ASSOCIATES, and Claraphi Advisory Network, LLC.
This table shows 235 institutional shareholders of the security as of 30 Sep 2020.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.